MedTrace Logo

Efficacy Study of Ketorolac and HPMC to Treat Dry Eye

NCT03693183 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2024-04-24

No results posted yet for this study

Summary

The purpose of this study is to determine whether ketorolac and Hydroxypropyl Methylcellulose are effective in the treatment of Dry Eye.

Conditions

  • Dry Eye

Interventions

DRUG

Ketorolac/HPMC

0.30% Ketorolac/0.80%HPMC Ophthalmic solution administered 4 times per day for 2 days

DRUG

HPMC

0.80% Hydroxypropyl Methylcellulose solution 4 times per day for 2 days

DRUG

Vehicle

Vehicle

Sponsors & Collaborators

  • ORA, Inc.

    lead INDUSTRY

Principal Investigators

  • H. Jerome Crampton, MD · Ophthalmic Reserach Associates

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2009-06-15
Completion
2009-06-15
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03693183 on ClinicalTrials.gov